A new trading day began on Friday, with Profound Medical Corp (NASDAQ: PROF) stock price down -23.29% from the previous day of trading, before settling in for the closing price of $5.54. PROF’s price has ranged from $3.89 to $9.87 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 3.91% over the past five years. Meanwhile, its annual earnings per share averaged -33.26%. With a float of $26.58 million, this company’s outstanding shares have now reached $30.05 million.
Let’s look at the performance matrix of the company that is accounted for 142 employees. In terms of profitability, gross margin is 66.75%, operating margin of -185.15%, and the pretax margin is -283.93%.
Profound Medical Corp (PROF) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Profound Medical Corp is 11.55%, while institutional ownership is 42.31%. The most recent insider transaction that took place on May 16 ’25, was worth 56,888. In this transaction CEO of this company bought 12,027 shares at a rate of $4.73, taking the stock ownership to the 587,089 shares. Before that another transaction happened on May 15 ’25, when Company’s CEO bought 10,003 for $4.33, making the entire transaction worth $43,263. This insider now owns 575,062 shares in total.
Profound Medical Corp (PROF) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.38 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -33.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.51% during the next five years compared to 3.91% growth over the previous five years of trading.
Profound Medical Corp (NASDAQ: PROF) Trading Performance Indicators
Here are Profound Medical Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.45, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.31 in one year’s time.
Technical Analysis of Profound Medical Corp (PROF)
Profound Medical Corp (NASDAQ: PROF) saw its 5-day average volume 0.14 million, a positive change from its year-to-date volume of 67532.0. As of the previous 9 days, the stock’s Stochastic %D was 32.53%.
During the past 100 days, Profound Medical Corp’s (PROF) raw stochastic average was set at 10.16%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.34 in the past 14 days, which was lower than the 0.37 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.88, while its 200-day Moving Average is $6.38. Nevertheless, the first resistance level for the watch stands at $4.95 in the near term. At $5.65, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.00. If the price goes on to break the first support level at $3.90, it is likely to go to the next support level at $3.55. The third support level lies at $2.85 if the price breaches the second support level.
Profound Medical Corp (NASDAQ: PROF) Key Stats
With a market capitalization of 127.71 million, the company has a total of 30,053K Shares Outstanding. Currently, annual sales are 10,680 K while annual income is -27,820 K. The company’s previous quarter sales were 2,620 K while its latest quarter income was -10,720 K.
